$ESAB

ESAB Corp (ESAB): Results of Operations and Financial Condition

ESAB Corp (ESAB) filed an SEC Form 8-K — Results of Operations and Financial Condition. ESAB Corporation Announces Second Quarter 2026 Results • Record total sales increased 12.9%, with core organic sales up 2.5% • Core organic growth in both segments • Closed Eddyfi ahead of schedule • Updating 2026 outlook North Bethesda, MD, August 6, 2026 -- ESAB Corporation (“E

Original reporting
Published Aug 6, 2026, 10:31 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 10:35 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$ESAB
Bullish
high confidence
Mentioned
$ESAB
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ESABBullishHigh
01

Why it matters

The key tradable items are the raised full-year core sales growth range, higher core adjusted EBITDA forecast, and updated core adjusted EPS range, plus the acquisition of Eddyfi closing one month ahead of schedule.

02

Market read

A same-day guidance raise with quantified EBITDA and EPS targets is a direct input to valuation models and near-term positioning.

03

What to watch

The filing emphasizes core organic growth and M&A contribution; traders may need to separate organic momentum from acquisition-driven growth when assessing sustainability.

Relevance 7/10Novelty 9/10Timing: pre-market today, filed Aug 6, 2026 with Q2 results and raised FY 2026 guidance
alphai · Earnings readESAB · second quarter 2026 · ended July 3, 2026

Record total sales increased 12.9%, with core organic sales up 2.5%; Eddyfi acquisition closed ahead of schedule; 2026 outlook updated.

Solid quarter

ESAB delivered record $808 million second-quarter sales, returned to core organic growth in both segments, and raised full-year core sales growth and core adjusted EBITDA outlook. Core adjusted EBITDA margin declined by 90 basis points to 19.5% and core adjusted net income was down 1% year over year.

EPS · non-GAAP
$1.33 diluted earnings
down 1% on a year-over-year basis y/y
full-year 2026 outlook
total core sales growth of 11.0% to 14.0%

Key metrics

as reported
MetricValueq/qy/y
SalesGAAP$808 million12.9%
Core organic sales growthnon-GAAP2.5%2.5%
Net income from continuing operations attributable to ESABGAAP$35 million
Diluted earnings per shareGAAP$0.54 diluted earnings per share
Core adjusted net incomenon-GAAP$83 milliondown 1% on a year-over-year basis
Core adjusted net income per diluted sharenon-GAAP$1.33 diluted earnings per sharedown 1% on a year-over-year basis
Core adjusted EBITDAnon-GAAP$150 million8.0%
Core adjusted EBITDA marginnon-GAAP19.5%decreased by 90 basis points on a year-over-year basis

full-year 2026 outlook

  • Revenuetotal core sales growth of 11.0% to 14.0%
  • NoteCore organic sales of 2.0% to 4.0%
  • NoteM&A contribution of approximately 9.0%
  • NoteFX impact of 0.0% to 1.0%
  • NoteCore adjusted EBITDA of $615 million to $625 million
  • NoteCore adjusted EPS of $5.40 to $5.50

What drove it

  • Record second quarter sales increased 12.9% on a reported basis.
  • Core organic sales increased 2.5% before acquisitions and currency translation.
  • The company reported core organic growth in both segments.
  • Management cited particular strength in North America and Asia and a resilient Europe.
  • The acquisition of Eddyfi closed one month ahead of schedule.
  • Management expects to mitigate transitory cost inflation related to logistics and commodity price increases over the next few quarters.

Concerns

  • Core adjusted EBITDA margin decreased by 90 basis points on a year-over-year basis to 19.5%.
  • Management attributed margin pressure to transitory price/cost neutrality and targeted commercial investments for equipment growth.
  • Management described the macro environment as challenging and cited a challenging environment in the Middle East.
  • The filing identifies logistics and commodity price increases as transitory cost inflation.

What to watch

  • Delivery of full-year total core sales growth of 11.0% to 14.0%.
  • Whether core organic sales reaches the guided 2.0% to 4.0% range.
  • The contribution from M&A, guided at approximately 9.0%, following the Eddyfi acquisition closing.
  • Mitigation of logistics and commodity cost inflation over the next few quarters.
  • Core adjusted EBITDA delivery within the raised $615 million to $625 million range.
  • Progress toward the guided core adjusted EPS range of $5.40 to $5.50.

Analysis

ESAB reported record second-quarter sales of $808 million, up 12.9% on a reported basis, with core organic sales growth of 2.5%. The company said it returned to core organic growth in both segments. Management highlighted particular strength in North America and Asia, while characterizing Europe as resilient despite a challenging macro environment and conditions in the Middle East.

Profitability grew in dollar terms but margin performance was pressured. Core adjusted EBITDA rose 8.0% to $150 million, while core adjusted EBITDA margin decreased by 90 basis points year over year to 19.5%. ESAB attributed the margin decline to transitory price/cost neutrality and targeted commercial investments for equipment growth. Core adjusted net income was $83 million, or $1.33 diluted earnings per share, down 1% on a year-over-year basis. GAAP net income from continuing operations attributable to ESAB was $35 million, or $0.54 diluted earnings per share.

The acquisition of Eddyfi closed one month ahead of schedule. Management called the transaction a defining step toward extending workflow solutions into new adjacencies and described the resulting company as a higher-growth, higher-margin enterprise. The updated outlook incorporates a higher expected M&A contribution of approximately 9.0%, compared with 4.0% in the prior outlook disclosed in the release.

For full-year 2026, ESAB raised total core sales growth guidance to 11.0% to 14.0% from 6.0% to 9.0% and raised core adjusted EBITDA guidance to $615 million to $625 million from $575 million to $595 million. Core organic sales guidance remains 2.0% to 4.0%, while FX impact guidance remains 0.0% to 1.0%. The key operating items are the pace of organic growth, realization of the increased M&A contribution, and management's stated mitigation of logistics and commodity cost inflation over the next few quarters.

Management, verbatim

ESAB delivered a record second quarter, with a solid return to organic growth in both regions, underscoring the strength of our platform even in a challenging macro environment.

Shyam P. Kambeyanda, ESAB President and CEO

We expect to mitigate the transitory cost inflation related to logistics and commodity price increases over the next few quarters.

Shyam P. Kambeyanda, ESAB President and CEO

We are also pleased to have closed our acquisition of Eddyfi one month ahead of schedule.

Shyam P. Kambeyanda, ESAB President and CEO

Not in the filing

stated, not guessed
  • Segment names, segment revenue, segment profitability, and segment-specific growth rates.
  • GAAP gross profit and gross margin.
  • GAAP operating income and operating margin.
  • GAAP total net income beyond net income from continuing operations attributable to ESAB.
  • Prior-year and prior-quarter absolute values for reported sales, net income, earnings per share, core adjusted net income, core adjusted EBITDA, and core adjusted EBITDA margin.
  • GAAP and non-GAAP operating cash flow.
  • Free cash flow or adjusted free cash flow.
  • Cash and cash equivalents.
  • Debt and net debt.
  • Share repurchases, dividends, and other capital-return figures.
  • Capital expenditures.
  • Tax rate.
  • Gross margin, operating-expense, and tax-rate guidance.
  • CFO commentary.
  • A separately provided previous outlook section for actual-versus-prior-guidance comparison.

AlphaAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Background

This is an SEC Form 8-K (Item 2.02) attaching ESAB’s Q2 2026 results press release and full-year 2026 outlook update.

Company-level read

Ticker impact

$ESABBullishHigh confidence
Context

ESAB reported Q2 2026 record sales and updated full-year 2026 outlook, raising core sales growth and EBITDA/EPS guidance.

Expected impact

Likely positive bias for ESAB shares into the next earnings cycle as raised EBITDA and EPS targets reduce downside risk.

Evidence & confidence

The filing includes specific, time-relevant guidance changes: core sales growth raised to 11.0% to 14.0%, core adjusted EBITDA to $615m to $625m, and core adjusted EPS to $5.40 to $5.50, alongside a completed Eddyfi acquisition ahead of schedule.

Market effects

Industrial welding and cutting consumables and workflow solutions peers may see read-across on demand resilience and margin normalization assumptions.

Management cites strength in North America and Asia and a challenging Middle East environment, which may influence regional industrial demand expectations.

FX and commodity/logistics transitory cost mitigation narrative can affect broader industrial compounder sentiment.

Counterpoint

Raised guidance may still embed margin pressure from transitory logistics and commodity costs, so upside could fade if costs do not normalize as expected.

Key entities

  • ESAB Corporation

    Industrial compounder reporting Q2 2026 results and raising FY 2026 core sales, EBITDA, and EPS guidance.

  • Eddyfi

    Workflow solutions acquisition closed one month ahead of schedule, supporting ESAB’s adjacency and growth strategy.

Every ESAB earnings report

This story covers one filing. The ticker page keeps them all: each quarter's reported metrics with year-over-year and sequential comparisons, segments, guidance, and how the numbers landed against the company's own prior outlook.

Related articles

$ESABMedAI 8/10

ESAB (ESAB) Q2 2026 Earnings Call Transcript

ESAB (ESAB) reported Q2 2026 core sales of $766 million, up 13% year over year, with 2.5% core organic growth. Adjusted EBITDA was $150 million, up 8%, and margin was 19.5%. Full-year guidance: core sales $3.0-$3.1B, adjusted EBITDA $615-$625M, adjusted EPS $5.40-$5.50, including Eddyfi. Middle East sales fell 10%-11% amid conflict.

$INFYMed

Aug 12: Markets Extend Losses as Tata Stocks, IT Shares Drag; Nifty Slips Below 24,450 – The Indian Awaaz

Indian benchmarks extended losses. The Nifty 50 fell 35.75 points, or 0.15%, to 24,435.95, and the Sensex dropped 187.90 points, or 0.24%, to 77,966.35. Tata stocks and IT shares weighed after Tata Sons chairman N Chandrasekaran said he will not seek reappointment. TCS fell 3.93% and Infosys 1.23%. India CPI inflation rose to 4.45% in July, from 4.38% in June.

$ESABMedAI 8/10

ESAB Q2 Deep Dive: Equipment Strength and Eddyfi Integration Drive Strategic Shift

ESAB reported Q2 revenue of $807.6 million, above analysts’ $787.2 million, with adjusted EPS of $1.33 versus $1.37 expected. Adjusted EBITDA was $151.4 million, slightly above estimates. Full-year adjusted EPS guidance of $5.45 and EBITDA guidance of $620 million both missed. Management cited equipment and automation strength and Eddyfi integration, while Middle East revenue fell due to geopolitical disruption and higher logistics costs.

$ESABMedAI 8/10

ESAB Q2 Earnings Call Highlights

ESAB (NYSE:ESAB) discussed its Q2 earnings call and Eddyfi integration. Management said Eddyfi has high-single-digit growth, ~65% gross margins and ~30% EBITDA margins, with a ~$450 million commercial funnel. ESAB raised FY2026 outlook to core sales of ~$3.0-3.1B, adjusted EPS $5.40-5.50, and adjusted EBITDA $615-625M.

$ESABMed

ESAB’s (NYSE:ESAB) Q2 CY2026 Sales Beat Estimates

ESAB (NYSE:ESAB) reported Q2 CY2026 revenue of $807.6 million, up 12.9% year over year, exceeding Wall Street estimates by 2.6%. Non-GAAP EPS was $1.33, down from $1.36 a year earlier and 3% below consensus. Operating margin fell to 9.7% from the prior year. Analysts expect full-year EPS to rise from $5.31 to $6.08.

$ESABMed

Q4 Results 29th May Live: Asian Paints, IndiGo, NMDC, Glenmark Pharma, Ipca Lab, IREDA, Gujarat Gas, Natco Pharma, Inox Wind, Rubicon Research, BEML, NMDC Steel, JM Financial, Triveni Engg to announce

The article previews Q4 results from multiple Indian companies and highlights several earnings updates. Prime Focus reported standalone net profit of Rs 4.32 crore for March 2026 quarter vs Rs 16.11 crore loss a year earlier. Alkem Laboratories’ standalone net profit fell to Rs 217 crore from Rs 276.9 crore; it recommended a final dividend of Rs 10/share. It also cites Q4FY26 figures for ESAB India, Ecos Mobility, and Ivalue Infosolutions, plus early stock moves.